Jianping Liu
Research Fellow
Research interest
Organic synthesis & biomedical applications
Education background
PhD, Biomedical Engineering, The University of Queensland, 2021
MSc, Materials Science, Tianjin University, 2016
BSc, Polymer Materials and Engineering, Ludong University, 2013
Email: jp.liu@nus.edu.sg
Publication
J. Liu, Y. Zhang, B. Yang, Y. Jia, R-t. Liu, L. Ding*, Z. Shen*, X. Chen*, Synergistic Glutathione Depletion and STING Activation to Potentiate Dendritic Cell Maturation and Cancer Vaccine Efficacy, Angew. Chem. Int. ed. 2024, n/a, e2023318530.
J. Liu, J. Zhan, Y. Zhang, L. Huang, J. Yang, J. Feng, L. Ding*, Z. Shen*, X. Chen*, Ultrathin Clay Nanoparticles-Mediated Mutual Reinforcement of Ferroptosis and Cancer Immunotherapy, Adv. Mater, 2023, n/a, 202309562.
J. Liu, L. Li, R. Zhang*, Z. P. Xu*; Adjacent Effect between Gadolinium(III) and Copper(II) in Clay Nanoparticles Synergistically Enhances T1-Weighted Magnetic Resonance Imaging Contrast Agent. Nanoscale Horiz., 2023, 8, 279-290.
S. Chen#, J. Yang#, Z. Liang#, Z. Li, W. Xiong, Q. Fan, Z. Shen*, J. Liu*, Y. Xu*; Synergistic Functional Nanomedicine Enhances Ferroptosis Therapy for Breast Tumors by a Blocking Defensive Redox System, ACS Appl. Mater. Interfaces, 2023, 15(2), 2705-2713.
J. Liu, K. Liu, L. Zhang, M. Zhong, T. Hong, R. Zhang, Y. Gao, R. Li, T. Xu*, Z. P. Xu*; Heat/pH-Boosted Release of 5-Fluorouracil and Albumin-Bound Paclitaxel from Cu-Doped Layered Double Hydroxide Nanomedicine for Synergistical Chemo-Photo-Therapy of Breast Cancer, J. Control. Release, 2021, 335, 49-58.
J. Liu#, M. Wu#, R. Zhang*; Z. P. Xu*; Oxygen-Derived Free Radicals: Production, Biological Importance, Bioimaging and Analytical Detection with Responsive Luminescent Nanoprobes, VIEW, 2021, 2(5),20200139.
J. Liu, L. Sun, L. Li, R. Zhang*, Z. P. Xu*; Synergistic Cancer Photochemotherapy via Layered Double Hydroxide-Based Trimodal Nanomedicine at Very Low Therapeutic Doses, ACS Appl. Mater. Interfaces, 2021, 13(6), 7115-7126.
H. Feng#, J. Liu#, A. Qaitoon#, Q. Meng, Y. Sultanbawa, Z. Zhang*, Z. P. Xu; R. Zhang*; Responsive Small-Molecule Luminescence Probes for Sulfite/Bisulfite Detection in Food Samples, TRAC-Trends Analyt. Chem., 2021, 136, 116199.
T. Xu#, J. Liu#, L. Sun, R. Zhang, Z. P. Xu*, Q. Sun*; Enhancing Tumor Accumulation and Cell Uptake of Layered Double Hydroxide Nanoparticles by Coating/Detaching pH-Triggered Charge-Convertible Polymer, ACS Omega, 2021, 6(5), 3822-3830.
X. Zhang#, Y. Fu#, J. Liu#, G. Qian, J. Zhang, R. Zhang*, Z. P. Xu*; A Hydrogen Peroxide Activatable Nanoprobe for Light-Controlled “Double-Check” Multicolor Fluorescence Imaging, Nanoscale, 2020, 12, 22527-22533.
J. Liu, Y. Wu, C. Fu, B. Li, L. Li, R. Zhang*, T. Xu, Z. P. Xu*; Charge Reversion Simultaneously Enhances Tumor Accumulation and Cell Uptake of Layered Double Hydroxide Nanohybrids for Effective Imaging and Therapy, Small, 2020, 16(31), 2002115.
C. Liu#, J. Liu#, W. Zhang, Y. Wang, Q. Liu, B. Song, J. Yuan*, R. Zhang*; “Two Birds with One Stone” Ruthenium(II) Complex Probe for Biothiols Discrimination and Detection in Vitro and in Vivo, Adv. Sci., 2020, 7(11), 2000458.
J. Liu#, C. Duan#, W. Wang, H. T. Ta, J. Yuan, R. Zhang*, Z. P. Xu*; Responsive Nanosensor for Ratiometric Luminescence Detection of Hydrogen Sulfide in Inflammatory Cancer Cells, Anal. Chim. Acta, 2019, 1103: 156-163.
J. Liu, R. Zhang*, Z. P. Xu*, Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions, Small, 2019, 15(32), 1900262.
Q. Feng#, J. Liu#, X. Li, Q. Chen, J. Sun*, X. Shi, B. Ding, H. Yu*, Y. Li, X. Jiang*; One-Step Microfluidic Synthesis of Nanocomplex with Tunable Rigidity and Acid-Switchable Surface Charge for Overcoming Cancer Drug Resistance. Small, 2017, 13(9), 1603109.
J. Zhang#, J. Liu#, L. Zhu, Z. Xu*, T. Wang, L. Lu, C. Feng, J. Xu, H. Yu*, W. Zhang*; Photodynamic Micelles for Amyloid-β Degradation and aggregation Inhibition. Chem. Commun., 2016, 52(81), 12044-12047.
J. Liu, T. Wang, D. Wang, A. Dong*, Y. Li, H. Yu*; Smart Nanoparticles for Therapy of the Drug-Resistant Tumors by Overcoming the Pathophysiological Barriers. Acta Pharmacol. Sin., 2016, 38(1), 1-8.